Online

24/7 knowledge networking from feed to food

news

Aromabiotic® Poultry - medium chain fatty acids in the battle against antimicrobial resistance

Aromabiotic® Poultry - medium chain fatty acids in the battle against antimicrobial resistance

In 2006, 96% of the birds slaughtered worldwide were given antibiotics somewhere in their lifetime.  There is a global concern and even demand to reduce the antibiotic use in poultry and in this way reduce the risk for antimicrobial resistance. Medium chain fatty acids make it possible to reduce the use of antibiotics without compromising bird performance and food safety.

Consequences of antimicrobial resistance

Antimicrobial resistance is a global problem. New resistance mechanisms emerge and spread globally threatening our ability to treat common infectious diseases, resulting in death and disability of individuals who until recently could continue a normal course of life. With the increasing resistance, many standard medical treatments will fail. Antimicrobial resistance also increases health care costs because of more expensive therapies, in case first-line antibiotics don’t work.

Infections caused by resistant microorganisms often even fail to respond to the standard treatment, and can result into death. According to the “Review on Antimicrobial Resistance”, published in 2014, 700 000 people per year die from antimicrobial resistance nowadays. If the global feed industry would continue to use antibiotics like nowadays, it is estimated that the number of deaths can increase until 10 million deaths per year in 2050. In that case, antimicrobial resistance would be the leading cause of death in the world (Figure 1).

figure1.png

Figure 1: Prediction of antimicrobial resistance deaths in 2050 compared to other causes of death (source: Review on Antimicrobial Resistance (AMR))

Antimicrobial growth promotion in poultry production

Antibiotic use in animal production has been practiced for about 50 years. Most of this use of antibiotics is as antibiotic growth promoters (AGP’s). AGP’s are the antibiotics that are continuously used in poultry feed at a low level to improve growth and feed conversion and not for the purpose of any therapeutic reasons.

One of the major current benefits of AGP use may be maintaining animal health in older facilities, where hygiene management is less efficient. Farms that produce broilers with AGP’s tend to have older houses, with less modern equipment, and are less likely to follow a plan for managing food safety hazards. AGP’s may have smaller benefits when production conditions are optimized: researchers demonstrated significantly smaller response in chicks to AGP’s in new environments compared to previously used environments (Coates et al, 1951).

An EU-wide ban on the use of antibiotics as growth promoters in animal feed was entering into effect on January 1st, 2006. The ban is the final step in the phasing out of antibiotics used for non-medicinal purposes. In Europe, people had to take action to accomplish the challenge: building new adapted poultry houses with sufficient climate control, proper hygiene and biosecurity at the farm, and also nutrition and additives are adapted.

In the US, AGP’s are not banned, but the FDA recently issued guidelines for the industry to voluntarily withdraw medically important antibiotics from growth promotion (FDA, 2013a). For policy makers, the challenge is to evaluate the benefits and costs of animal antibiotics to society. What is the economic value of antibiotics to the livestock industry versus the potential health cost of increasing resistance levels? What are the potential productivity and economic effects of a ban on AGP’s for US meat producers and consumers? All these questions should be solved first, but nonetheless a ban on AGP’s is expected in the US in 2017.

Aromabiotic® Poultry

Medium chain fatty acids (MCFA’s) are already used for a long time as alternative to antibiotics in poultry nutrition. Thanks to its broad antimicrobial and immune supporting...

Do you already have an account? Log in here

Join the discussion

0 comments

To read and post comments you need to login or register